معرفی
Clifford C Dacso, M.D., is a Professor at Baylor College of Medicine's Department of Molecular & Cellular Biology. He holds affiliations with the Center for Coregulator Research and is a Member of the Dan L Duncan Comprehensive Cancer Center. His educational background includes an MD from Baylor College of Medicine, an MPH from the University of Texas School of Public Health, an MBA from Pepperdine University, and advanced training in Microbiology and Immunology through a Fellowship at Baylor College of Medicine.
Dr. Dacso's research focuses on Clinical Metabolomics, Biosensors, and their applications in cancer, cardiovascular diseases, and immunology. His work integrates molecular biology with clinical translation, particularly in developing therapies targeting steroid receptor coactivators (SRCs) for cancer and stroke treatment. He has also contributed to the development of medical devices for real-time physiological monitoring in chronic diseases.
His recent publications highlight advancements in genomic engineering (e.g., CRISPR-Cas9 in T regulatory cells), metabolomics-based diagnostics for prostate cancer, and the role of SRC-3 in tumor immunity. He has consistently explored circadian rhythms and their impact on lipid metabolism and disease progression.
Dr. Dacso’s expertise spans academia and industry, with contributions to translational medicine and global health technologies. His lab actively collaborates on projects involving organoid models, immunotherapy, and biosensor innovation.
